GlassScriptPhysician profile
Darwin B Wooten
NPI 1275557613
$4,734.47
in general payments reported to CMS, 2019-2025
28 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $510 · 2021: $483 · 2022: $809 · 2023: $944 · 2024: $568 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,030 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,030.07 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,283.38 | 2019-2025 | Clareon, Hydrus Microstent, Argos |
| Mallinckrodt Hospital Products INC. | $550.86 | 2022-2025 | Acthar |
| Sight Sciences, INC. | $373.31 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $310.06 | 2019-2021 | |
| Ocular Therapeutix, INC. | $296.57 | 2020-2025 | Dextenza |
| Abbvie INC. | $282.72 | 2022-2025 | Durysta, Xen Glaucoma Treatment System |
| Rxsight INC | $272.45 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Eyepoint US, INC. | $229.39 | 2019-2020 | |
| Ivantis, INC | $176.18 | 2020-2021 | |
| Allergan, INC. | $125.50 | 2019-2021 | |
| Amgen INC. | $106.36 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $90.70 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $74.90 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Biotissue Holdings INC. | $70.59 | 2020-2023 | |
| Iridex Corporation | $63.39 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $55.42 | 2022 | |
| Harrow Eye, LLC | $51.46 | 2023-2024 | Iheezo, Vevye |
| Horizon Therapeutics Plc | $43.82 | 2023 | |
| Glaukos Corporation | $41.10 | 2025 | Idosetr |
| Omeros Corporation | $39.83 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $34.38 | 2024-2025 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $31.99 | 2019-2020 | |
| New World Medical,INC. | $31.89 | 2023-2025 | Via360, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Tarsus Pharmaceuticals, INC. | $25.26 | 2025 | Xdemvy |
| Dompe US, INC. | $20.07 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $18.31 | 2025 | Cirrus Hd-Oct |
| Eyevance Pharmaceuticals LLC | $18.22 | 2022 | |
| Thea Pharma INC. | $16.36 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darwin Wooten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.